Well the market has been savage with the company today. l wonder how many of the sellers undertand that although the trial failed to meet the endpoint (that only the FDA would dream up) that the future hasn't altered apart from a delay in first serious commercial revenues.
It has been proven an effective treatment and if the application plan was altered to perhaps once a day for 7 days then every second day for 2 further weeks then the result would probably have supported approval.
Unfortunately trial designs in this field appear very narrow in there scope and now many (as the market shows) are deeming the product a failure.
l listened to the conference call this morning where it was announced that it was being recorded. If it appears on their website its worth a listen.
Just have to wait a little longer for the inevitable payday.
Ann: VivaGel phase 3 study results , page-8
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |